p38
p38 (p38 mitogen-activated protein kinases) are serine/threonine kinases that activated by environmental stress and proinflammatory cydtokines. They mediates cell growth, differentiation, transcrption and development.
p38 相关产品(100)
- GC15814Pamapimod (R-1503, Ro4402257)CAS: 449811-01-2纯度: >99.50%
An orally bioavailable inhibitor of p38α MAP kinase
- GC18273SB 202190 (hydrochloride)CAS: 350228-36-3纯度: >99.50%
A potent and selective p38 MAP kinase inhibitor
- GC20007Ginsenoside CKCAS: 39262-14-1纯度: >98.00%
Ginsenoside CK,一种由主要人参皂苷化合物转化而来的次级人参皂苷,比其母体人参皂苷具有更高的生物利用度和溶解性,具有极其重要的意义。
- GC30158p38-α MAPK-IN-1CAS: 443913-15-3纯度: >99.50%
p38-α MAPK-IN-1 is an inhibitor of p38-α, with IC50 value of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay.
- GC30646Skatole(3-Methylindole)CAS: 83-34-1纯度: >99.50%
Skatole (3-methylindole, Scatole) is a mildly toxic white crystalline organic compound that occurs naturally in feces. It has a fairly broad bacteriostatic effect.
- GC31697Dilmapimod (SB-681323)CAS: 444606-18-2纯度: >99.50%
Dilmapimod (SB-681323,GW 681323) is a potent p38 MAPK inhibitor that potentially suppresses inflammation in chronic obstructive pulmonary disease.
- GC31988p38α inhibitor 1CAS: 1034189-82-6纯度: >98.50%
p38αinhibitor1是p38α的抑制剂,来自专利WO2008076265A1。
- GC32411FR 167653 (FR 167653 sulfate)CAS: 158876-66-5
FR 167653 (FR 167653硫酸盐) (FR 167653 (FR 167653硫酸盐)),一种具有口服活性和选择性的p38 MAPK抑制剂,是TNF-α的强效抑制剂;和 IL-1β;通过特异性抑制 p38 MAPK 活性产生。
- GC33229SJFαCAS: 2254609-27-1
SJFα是一种含13个原子连接桥的PROTAC。SJFα降解p38α,DC50为7.16nM,但降解p38δ效果较差(DC50=299nM),且在浓度高达2.5μM时也不会降解其他p38亚型(β和γ)。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC15814 | Pamapimod (R-1503, Ro4402257) | 449811-01-2 | >99.50% | |
An orally bioavailable inhibitor of p38α MAP kinase | ||||
| GC16019 | SB 202474 | 172747-50-1 | - | |
A negative control for SB 202190 and SB 203580 | ||||
| GC16997 | BMS-582949 | 623152-17-0 | - | |
A p38α MAP kinase inhibitor | ||||
| GC17725 | SKF 86002 dihydrochloride | 116339-68-5 | - | |
An anti-inflammatory agent | ||||
| GC17957 | SX 011 | 309913-42-6 | - | |
p38α inhibitor | ||||
| GC18273 | SB 202190 (hydrochloride) | 350228-36-3 | >99.50% | |
A potent and selective p38 MAP kinase inhibitor | ||||
| GC18602 | p38 MAPK Inhibitor IV | 1638-41-1 | >98.00% | |
An inhibitor of p38 MAP kinases | ||||
| GC19019 | Acumapimod | 836683-15-9 | >99.00% | |
An inhibitor of p38α MAPK | ||||
| GC19304 | R1487 Hydrochloride | 449808-64-4 | >98.50% | |
An inhibitor of p38α MAPK | ||||
| GC19325 | SD 0006 | 271576-80-8 | >98.50% | |
An inhibitor of p38α MAPK | ||||
| GC19366 | UM-164 | 903564-48-7 | >98.50% | |
An inhibitor of Src and p38 MAPK kinases | ||||
| GC20007 | Ginsenoside CK | 39262-14-1 | >98.00% | |
Ginsenoside CK,一种由主要人参皂苷化合物转化而来的次级人参皂苷,比其母体人参皂苷具有更高的生物利用度和溶解性,具有极其重要的意义。 | ||||
| GC30158 | p38-α MAPK-IN-1 | 443913-15-3 | >99.50% | |
p38-α MAPK-IN-1 is an inhibitor of p38-α, with IC50 value of 2300 nM in EFC displacement assay, and 5500 nM in HTRF assay. | ||||
| GC30609 | p38 MAPK-IN-2 | 635725-16-5 | - | |
p38MAPK-IN-2是一种p38kinase的抑制剂。 | ||||
| GC30646 | Skatole(3-Methylindole) | 83-34-1 | >99.50% | |
Skatole (3-methylindole, Scatole) is a mildly toxic white crystalline organic compound that occurs naturally in feces. It has a fairly broad bacteriostatic effect. | ||||
| GC30676 | MAPK13-IN-1 | 229002-10-2 | >98.00% | |
MPAK13-IN-1是MAPK13(p38δ)的一个抑制剂,其IC50值为620nM。 | ||||
| GC31058 | FR 167653 free base | 158876-65-4 | - | |
FR-167653是一种选择性的p38MAPK抑制剂。 | ||||
| GC31697 | Dilmapimod (SB-681323) | 444606-18-2 | >99.50% | |
Dilmapimod (SB-681323,GW 681323) is a potent p38 MAPK inhibitor that potentially suppresses inflammation in chronic obstructive pulmonary disease. | ||||
| GC31924 | AZD7624 | 1095004-78-6 | >98.00% | |
AZD7624是一种可吸入的p38抑制剂,具有高效的抗炎活性。 | ||||
| GC31988 | p38α inhibitor 1 | 1034189-82-6 | >98.50% | |
p38αinhibitor1是p38α的抑制剂,来自专利WO2008076265A1。 | ||||
| GC32209 | ITX5061 | 1252679-52-9 | >98.00% | |
ITX5061是一个II型p38MAPK抑制剂,也是清道夫受体B1(SR-B1)的拮抗剂。 | ||||
| GC32411 | FR 167653 (FR 167653 sulfate) | 158876-66-5 | - | |
FR 167653 (FR 167653硫酸盐) (FR 167653 (FR 167653硫酸盐)),一种具有口服活性和选择性的p38 MAPK抑制剂,是TNF-α的强效抑制剂;和 IL-1β;通过特异性抑制 p38 MAPK 活性产生。 | ||||
| GC33008 | p38 MAPK-IN-1 | 1006378-90-0 | >99.50% | |
p38MAPK-IN-1是p38MAPK新型高效选择性抑制剂,IC50值68nM。 | ||||
| GC33229 | SJFα | 2254609-27-1 | - | |
SJFα是一种含13个原子连接桥的PROTAC。SJFα降解p38α,DC50为7.16nM,但降解p38δ效果较差(DC50=299nM),且在浓度高达2.5μM时也不会降解其他p38亚型(β和γ)。 | ||||
